Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples